Randomized Trial of Early Versus Standard Drainage Removal After Pancreatic Resections

This study has been completed.
Information provided by:
Universita di Verona
ClinicalTrials.gov Identifier:
First received: May 28, 2009
Last updated: July 1, 2009
Last verified: July 2009
Despite a substantial decrease in postoperative mortality, morbidity after pancreatic resections is still high, even at high-volume centers. It has been recently suggested that early removal of postoperative drainages is associated to a decreased rate of intra-abdominal complications, with particular regard to pancreatic fistula. Furthermore, our research group demonstrated that measuring amylase value in drainages (AVD) on postoperative day 1 plays a cardinal role in predicting the developement of abdominal complications, including pancreatic fistula. In particular, patients with an AVD lower than 5000 IU/L in postoperative day 1 were considered at low risk of fistula. Therefore, the investigators designed a randomized prospective trial on early (postoperative day 3) versus standard (postoperative day 5) drainages removal after pancreatic resections in patients at low risk of developing pancreatic fistula (AVD < 5000 IU/L in postoperative day 1) to test whether drainages "per se" influence postoperative complication rates and to eventually validate a fast-track policy in pancreatic resections.

Condition Intervention
Distal Pancreatectomy
Pancreatic Fistula
Abdominal Abscess
Procedure: Postoperative drain removal

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Prevention
Official Title: Early Versus Standard Drainage Removal After Pancreatic Resections: Results of a Prospective Randomized Clinical Trial

Resource links provided by NLM:

Further study details as provided by Universita di Verona:

Primary Outcome Measures:
  • Abdominal Complications [ Time Frame: 1 month ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • In-hospital stay [ Time Frame: 1 month ] [ Designated as safety issue: No ]
  • Pulmonary complications [ Time Frame: 1 month ] [ Designated as safety issue: No ]
  • Hospital readmission [ Time Frame: 1 month ] [ Designated as safety issue: No ]

Enrollment: 114
Study Start Date: March 2007
Study Completion Date: April 2008
Arms Assigned Interventions
Active Comparator: Early drain removal
Drain removal in postoperative day 3
Procedure: Postoperative drain removal
removal of postoperative drainages at different time points (postoperative day 3 versus postoperative day 5)
Active Comparator: Standard drain removal
Drain removal on postoperative day 5
Procedure: Postoperative drain removal
removal of postoperative drainages at different time points (postoperative day 3 versus postoperative day 5)


Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Patients undergone either pancreaticoduodenectomy (reconstruction by pancreaticojejunostomy) or distal pancreatectomy with an amylase value in drains on postoperative day 1 less than 5000 IU/L

Exclusion Criteria:

  • Pancreaticoduodenectomy reconstructed with pancreaticogastrostomy
  • Clinical suspect of postoperative haemorrhage within 72hours after the operation
  • Clinical suspect of biliary fistula
  • Fluid collection greater than 3cm at an ultrasound carried out on postoperative day 3
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00931554

General Surgery B, Policlinico G.B. Rossi
Verona, Italy, 37134
Sponsors and Collaborators
Universita di Verona
  More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Claudio Bassi MD, Professor of Surgery, Department of Surgical and Gastroenterological Sciences, University of Verona
ClinicalTrials.gov Identifier: NCT00931554     History of Changes
Other Study ID Numbers: DREN-01 
Study First Received: May 28, 2009
Last Updated: July 1, 2009
Health Authority: Italy: Ethics Committee

Additional relevant MeSH terms:
Abdominal Abscess
Pancreatic Fistula
Digestive System Diseases
Digestive System Fistula
Pancreatic Diseases
Pathological Conditions, Anatomical

ClinicalTrials.gov processed this record on May 26, 2016